Supplement: Success with Toric and Presbyopia-Correcting IOLs in Today's Practice

Assessing baseline trends for treatment of astigmatic and presbyopic patients: A review of the 2022 ESCRS Clinical Trends Survey data.

Read the Supplement

Evolving technologies opening new doors to best treatments.

Hyperopia patients can expect a rise in the array of treatments.

Commitment to evidence-based medicine anchors studies and other projects.

Early results suggest subconjunctival 10 mg triamcinolone an effective strategy for dropless cataract surgery.

One surgeon’s tale of rising above stress.

Forthcoming position paper to provide an updated and expanded view on evaluation and management.

AI system measures eye stability and centration in procedures.

Good ideas lead to solutions to unmet needs.

Hyperopia treatment receives CE approval; mixed astigmatism may follow.